반응식
CS([C:4]1[N:9]=[C:8]([C:10]2[N:14]3[CH:15]=[CH:16][CH:17]=[C:18]([C:19]([OH:22])([CH3:21])[CH3:20])[C:13]3=[N:12][CH:11]=2)[CH:7]=[CH:6][N:5]=1)=O.[NH2:23][CH:24]1[CH2:29][CH2:28][CH:27]([NH:30][S:31]([CH3:34])(=[O:33])=[O:32])[CH2:26][CH2:25]1>CN1C(=O)CCC1.O>[OH:22][C:19]([C:18]1[C:13]2[N:14]([C:10]([C:8]3[CH:7]=[CH:6][N:5]=[C:4]([NH:23][CH:24]4[CH2:29][CH2:28][CH:27]([NH:30][S:31]([CH3:34])(=[O:33])=[O:32])[CH2:26][CH2:25]4)[N:9]=3)=[CH:11][N:12]=2)[CH:15]=[CH:16][CH:17]=1)([CH3:20])[CH3:21]참가 물질
5
반응물 2
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 105 °C
실험 절차
A mixture of 2-[3-(2-methanesulfinyl-pyrimidin-4-yl)-imidazo[1,2-a]pyridine-8-yl]-propan-2-ol (0.15 g) and N-(4-amino-cyclohexyl)-methanesulfonamide (0.325 g) in NMP (1.5 mL) was treated with TEA (0.33 mL) and heated at 105° C. for 18 h. The reaction mixture was then cooled to RT and diluted with water. The resulting precipitate was filtered, washed with water, and dried. The product was purified by ISCO using 100% DCM to 15% MeOH/DCM. Pure fractions were collected, concentrated, and titurated with EtOAc. The resulting solid was filtered and dried at 50° C. under vacuum overnight to provide N-(4-{4-[8-(1-hydroxy-1-methyl-ethyl)-imidazo[1,2-a]pyridine-3-yl]-pyrimidin-2-ylamino}-cyclohexyl)-methanesulfonamide (compound 3, 84.9 mg).
후처리
- temperatureThe reaction mixture was then cooled to RT
- filtrationThe resulting precipitate was filtered
- washwashed with water
- customdried
- customThe product was purified by ISCO
- customPure fractions were collected
- concentrationconcentrated
- filtrationThe resulting solid was filtered
- customdried at 50° C. under vacuum overnight
출처 및 근거
- ORD 기록
- ord-ff4c82885dc34545a3e02abac5381f64
- 출처 데이터셋
- uspto-grants-2013_10
- 특허 번호
- US08569306B2
연결된 노트
불러오는 중…